- امروز : چهارشنبه, ۲۸ آذر , ۱۴۰۳
- برابر با : Wednesday - 18 December - 2024
اخبار ویژه
Silent Damage First: Alzheimer’s Disease Could Have Two Phases
Sports Concussion Outcomes Can Be Made Worse By Depression
Dad’s Use of Diabetes Med Metformin Won’t Raise Birth Defect Risk
Fitness, Activity Boosts Kids’ Mental Health, Too
Exercise in Pregnancy Might Lower Baby’s Odds for Asthma Later
Some IUDs May Raise The Odds for Breast Cancer, But Overall Risk Remains Low
Music Might Speed Your Recovery From Surgery
A Cancer Diagnosis Takes Devastating Toll on Family Finances
پزشکی - Page 3 of 12
Dad’s Use of Diabetes Med Metformin Won’t Raise Birth Defect Risk
A new, reassuring study finds that men can take the diabetes drug metformin without worrying that their offspring will suffer from birth defects.
Few Heart Attack Survivors Get Expert Advice on Diet
Less than one-quarter of people who survive serious heart conditions receive the dietary counseling needed to protect their future health, a new study finds.
Too Many Teens Are Driving Drowsy
Teens on the verge of falling asleep behind the wheel is a common threat to public safety on U.S. roadways, a new study reports.
CDC Supports Use of Antibiotic as ‘Morning After Pill’ to Stop STDs
In new guidelines released Tuesday, U.S. health officials now recommend that certain people take the antibiotic doxycycline as a morning-after pill to lower the risk of some sexually transmitted diseases (STDs).
Chemo Before, After Surgery Could Help Those Battling Esophageal Cancer
People battling advanced esophageal cancers should get doses of chemotherapy both before and after tumor-removing surgeries, a new study suggests.
Wegovy, Ozempic May Help Curb Alcohol Dependence
Could the blockbuster GLP-1 meds like Wegovy and Ozempic have a role to play in helping people cut down on problem drinking? A new study suggests so.
Nerve Surgery May Help Some Battling Severe Migraine
Nerve surgery can reduce the number of headache days for people who suffer frequent migraines, a new review finds.
Gene-Targeted Immunotherapy Boosts Survival for Some Colon Cancer Patients
There's potential good news for a sizable minority of people battling advanced colon cancer.
Perioperative Nivolumab Tops Chemo for Survival in Resectable Lung Cancer
Significantly more patients had 18-month event-free survival in nivolumab versus chemotherapy group.
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 12
- Next Page »
